Aptose Biosciences
APTO
#10464
Rank
A$6.59 M
Marketcap
A$2.58
Share price
0.00%
Change (1 day)
726.43%
Change (1 year)

Aptose Biosciences (APTO) - Total assets

Total assets on the balance sheet as of March 2025 : A$11.27 Million

According to Aptose Biosciences's latest financial reports the company's total assets are A$11.27 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Aptose Biosciences - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2023-12-31A$19.06 M-74.57%
2022-12-31A$74.98 M-34.13%
2021-12-31A$0.11 B-30.68%
2020-12-31A$0.16 B14.42%
2019-12-31A$0.14 B499.28%
2018-12-31A$23.94 M56.22%
2017-12-31A$15.32 M27.8%
2016-12-31A$11.99 M-43.09%
2015-12-31A$21.07 M
2014-05-31A$30.6 M2846.79%
2013-05-31A$1.03 M55.73%
2012-05-31A$0.66 M-50.23%
2011-05-31A$1.33 M-48.86%
2010-05-31A$2.61 M-69.26%
2009-05-31A$8.52 M-30.29%
2008-05-31A$12.22 M-28.01%
2007-05-31A$16.97 M21.98%
2006-05-31A$13.91 M-51.77%
2005-05-31A$28.86 M-18.44%
2004-05-31A$35.38 M-7.61%
2003-05-31A$38.3 M-30.67%
2002-05-31A$55.24 M-29.52%
2001-05-31A$78.37 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Advaxis
ADXS
A$25.03 M 122.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
A$0.18 B 1,575.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
A$1.24 B 10,909.79%๐Ÿ‡บ๐Ÿ‡ธ USA